Machine learning and deep learning combined with radiomics have excellent potential for preoperative diagnosis, staging, and therapeutic effect evaluation of gliomas (7, 8), as well as for predicting IDH mutation status. This evidence concerns the gene IDH1 and central nervous system cancer.